Trump's remarks came a day before the Fed was set to announce its next decision on interest rates.Politicsread more
The U.S. and China have imposed tariffs on billions of dollars' worth of one another's goods since the start of 2018.Traderead more
More and more American firms are calling for the Trump administration to resolve its conflict with China.World Economyread more
In a tweet, Trump said that he and Xi "had a very good telephone conversation," and that "our respective teams will begin talks prior to our meeting."Politicsread more
China is reducing support for its electric carmakers a move experts and industry insiders warn could lead to consolidation and waning investor appetite. But some of the...Technologyread more
Is your CEO on the list? Glassdoor has the results.Power Playersread more
Joseph Gaspar, the chief financial officer at Elbit Systems, said M&A among firms in the sector began to pick up pace in the 1980s and looks set to continue.Paris Air Showread more
Stocks in Asia rose on Wednesday following positive developments overnight on the U.S.-China trade front.Asia Marketsread more
The U.S. Department of Defense has hit back at Russian officials who have criticized a U.S. plan to deploy more troops to the Middle East.World Politicsread more
Signs of companies moving out of Hong Kong have emerged, members of the business community told CNBC following massive protests in the city. But one analyst said Hong Kong's...China Politicsread more
The European Central Bank's (ECB) vice president said another large bond-buying program could be an option if inflation in the region doesn't reach its intended target.Europe Newsread more
While the initial panic or hysteria may have dissipated, the threat of Ebola remains imminent, survivor and missionary Dr. Kent Brantly said Tuesday.
"The public is not always aware of what's happening in West Africa, but we're still seeing 20 to 30 new cases of the disease in Sierra Leone and Guinea every week," Brantly said in a CNBC "Squawk on the Street " interview.
On Tuesday, biopharmaceutical company Novavax said its experimental vaccine, the Ebola GP Vaccine, induced a substantial immune response to the disease in an early-stage trial.
Nevertheless, there is still a long way to go before a definitive cure against the disease is found, Brantly added. "I think it's going to take some time to get substantial data back on those trials, but there are lots of different trials under way in West Africa and even here in the United States."
Brantly contracted the virus while treating patients in West Africa last year amid the largest Ebola epidemic to date.